Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 72.76 -1.11%   SPY: 163.45 -1.38%
Discuss Index Tracked By  


  Track the *RXFLU Index  

Swine Flu and Bird Flu Stocks (*RXFLU)

  Swine and Bird Flu Ideas       Swine and Bird Flu Performance       Swine and Bird Flu Community  
 
Popular long ideas:
Popular short ideas:
Top dividend plays:
Pro favorites:
GILD, GSK, NVS
SVA, NVAX, GSK
GSK, NVS, BAX
GILD, NVS, BAX
 
Index Description: These companies all produce or are investigating production of treatments and vaccines for swine flu, bird flu, and other similar flu-like diseases with pandemic potential. Also included are companies that produce flu diagnostic tests.
     
Today:
1-month:
All-time:
+2.4%
+4.1%
+140.3%
vs S&P 500:
vs S&P 500:
vs S&P 500:
+3.7%
+6.2%
+122.0%
Data since: Jan-01-2008
 
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
$45.0B
25.3
0.8%
     
569 members Tracking
Share this Index on Facebook
Share this Index on Twitter
 
                     
     
 
Chart View
1 week
 
1 month
 
3 months
 
6 months
 
All Time
 
 
 
 
 
 
 
   
     
 
Portfolio Detail
 
  Standard View     Performance View     Ideas & Research    
Click a column to sort | Scroll over columns for more information
 
 Ticker Last Trade Today's Change Volume  % of
Daily
Mkt Cap  Div Yield  % off
52wk lw
% from
52wk hg
Alerts
 APT $1.60 0.00 -0.0% 8,012 19% $31.2M - 26% -18% No Alerts/News
 AZN $50.19 -0.79 -1.6% 1,166,521 62% $63.7B 5.5% 18% -6% 1 Alert (1 News) - View
 BAX $69.66 -1.22 -1.7% 2,108,540 53% $38.4B 2.8% 38% -6% No Alerts/News
 BCRX $1.71 -0.08 -4.5% 477,614 60% $92.0M - 58% -65% No Alerts/News
 DVAX $1.13 +0.09 +8.7% 6,754,395 193% $190.2M - 14% -78% 4 Alerts (2 News) - View
 GILD $50.60 -1.34 -2.6% 6,406,707 55% $79.1B - 104% -13% 1 Alert (0 News) - View
 GNBT $0.04 0.00 +1.7% 676,090 14% $19.9M - 76% -65% No Alerts/News
 GSK $51.48 -0.99 -1.9% 1,913,131 73% $129.1B 4.5% 24% -5% 1 Alert (1 News) - View
 HEB $0.25 0.00 -1.5% 387,915 40% $41.9M - 37% -78% No Alerts/News
 INO $0.69 0.00 -0.6% 758,372 56% $125.7M - 73% -16% No Alerts/News
 NVAX $1.89 -0.04 -2.1% 462,887 33% $291.9M - 54% -32% No Alerts/News
 NVS $71.90 -1.22 -1.7% 1,003,846 70% $179.6B 2.8% 33% -5% 3 Alerts (2 News) - View
 PURE $0.39 -0.02 -4.4% 34,532 47% $4.9M - 77% -90% No Alerts/News
 QDEL $24.95 -0.46 -1.8% 45,609 28% $857.3M - 67% -5% No Alerts/News
 RHHBY $61.90 -0.55 -0.9% 134,169 28% $215.4B 2.6% 50% -7% 1 Alert (0 News) - View
 SNY $53.40 -1.16 -2.1% 541,789 50% $146.3B 2.3% 50% -5% 1 Alert (1 News) - View
 SRPT $39.78 +1.63 +4.3% 3,238,171 283% $1.2B - 1105% -12% 2 Alerts (0 News) - View
 SVA $4.01 -0.04 -1.0% 33,109 15% $223.1M - 103% -21% No Alerts/News
 VICL $3.11 +0.03 +1.0% 927,844 110% $265.8M - 19% -34% No Alerts/News
Is this index incomplete or incorrect?
Got an idea for a new Index?
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
 
Pharma Rx? $105B Saved If Patients Took Meds
PFE  JNJ  MRK  NVS  SNY  GSK  
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - June 19, 04:18PM from (ycharts.com)
Waste not, want not? Given the state of the US health care system – prescriptions, procedures and hospital emergency room  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
E.U. Fines Drug Companies for Delaying Generics
JNJ  MRK  NVS  
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - June 19, 07:49AM from (www.nytimes.com)
Antitrust regulators levied a total of $195.5 million in penalties for what they said were companies’ attempts to block  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Medtronic Saga: Corrupt Science, Belated Warning
BMY  LLY  MDT  MRK  NVO  AZN  ABBV  
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - June 18, 12:36PM from (ycharts.com)
As the result of an unusual effort designed to bolster transparency in clinical trials, two independent analyses have found  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Outside Review of Clinical Data Finds a Spinal Treatment’s Benefit Overstated
MDT  GSK  
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - June 17, 05:00PM from (www.nytimes.com)
Independent reviews of clinical trial data concluded that Infuse, a bioengineered bone product, was not significantly better  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pharma Stocks: Court Ruling's Real Meaning
BMY  LLY  PFE  MRK  AZN  SNY  GSK  
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - June 17, 01:51PM from (ycharts.com)
After years of anticipation and considerable debate, the US Supreme Court has ruled that drugmakers can face lawsuits over  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Merck HPV Vaccine Sales Surge Despite Concerns
MRK  GSK  
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - June 17, 12:27PM from (ycharts.com)
In the latest blow to drugmakers that market HPV vaccines, the Japanese health ministry has withdrawn its recommendation  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
UBS Dividend Ruler Stocks Combine Solid Yield and Growth Prospects
AFL  INTC  MDT  CSX  OXY  TEVA  AZN  BTI  UBS  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - June 17, 08:10AM from (247wallst.com)
Over the past five weeks, the 10-year Treasury bond yield has increased by over one-half of one percent from 1.66% to 2.17%.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Questcor Pays $135 Million for Rights to Competitor’s Drug
NVS  
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - June 14, 05:50PM from (www.nytimes.com)
The pharmaceutical company, which sells a treatment for immune-related ailments at $28,000 a vial, bought a much cheaper  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Closing Bell for Thursday on Wall Street: Markets Recoup from Low Open to Post Gain
HRB  BA  GCI  IP  PVH  SFD  BLC  WM  AMSC  MW  CPST  DVAX  AU  TWX  RH  COTY  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - June 13, 04:05PM from (247wallst.com)
U.S. equity markets opened lower this morning, but gathered steam following encouraging reports on new claims for jobless  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Growing Uses For $4B-a-Year Gilead HIV Drugs
GILD  
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - June 13, 01:32PM from (ycharts.com)
Less than a year after the FDA endorsed the notion of using medications to prevent HIV, a new study has found using the Viread  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains
CELG  BIIB  VRTX  GILD  ALXN  ONXX  OREX  TSRX  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - June 13, 08:15AM from (247wallst.com)
The higher the market climbs, the harder it becomes for investors to find solid stock ideas to add or scale in to their portfolios.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Gilead's Viread Reduces HIV Risk for Drug Users in Study
GILD  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - June 12, 03:03PM from (www.bloomberg.com)
Gilead Sciences Inc. (GILD)’s Viread pill reduced the risk of injected-drug users contracting the AIDS virus by half in  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Short Interest Falls in Vertex, Rises in Biogen Idec
BMY  PFE  MRK  AMGN  CELG  REGN  BIIB  VRTX  VVUS  GILD  ALXN  PCYC  ONXX  ARNA  DNDN  ILMN  NVS  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - June 12, 01:29PM from (www.benzinga.com)
Among biotech and emerging pharmaceutical companies, Biogen Idec (NASDAQ: BIIB), saw the most significant rise in short interest  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
After A Good Run, Novartis Looks Fairly Valued
BMY  MRK  BIIB  RHHBY  NVS  
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - June 12, 01:05PM from (www.investopedia.com)
Novartis is a well-balanced, high-quality pharma with growth credentials, but also a fair valuation today.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
What We're Reading ~ Analytical Links 6/12/13
AZN  BRK.B  P  CWGL  BRK.A  
Linked by market folly ( track newsfeed | ignore newsfeed ) - June 12, 12:52PM from (www.marketfolly.com)
Buffett, Robertson, Cooperman & more: words of wisdom from 18 wealth wizards [Forbes]



Why value investing works [ValueWalk]
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Vical to Present at Wells Fargo Securities Healthcare Conference
VICL  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - June 12, 06:43AM from (globenewswire.com)
SAN DIEGO, June 12, 2013 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
How Novartis Sales Culture Went Bad in India
NVS  
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - June 11, 04:27PM from (ycharts.com)
In yet another scandal at Novartis (NVS), the drug maker is investigating a widespread effort in India where numerous managers  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
UBS Top Dividend Growing Stocks to Buy for Income
BAX  CAG  F  NUE  BBT  WMB  JNJ  ESV  KLAC  AAPL  CSCO  UBS  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - June 11, 08:30AM from (247wallst.com)
Over the past month, interest rates have bounced off of their 2013 lows, with the U.S. 10-year yield quickly rising from  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 157



Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.

Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.

Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.

Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.

Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.

Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.

Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
tickerspy Indexes use a "net asset value" calculation. The components are equally weighted at the inception of the Index (typically 1/1/2008) and over time as some stocks go up and others go down, the relative weights of the components shift accordingly.
Click to close X

We look at the recent net stock adds (people adding a stock to their portfolio minus people removing it) and compare against the company's previous history to identify those companies that are seeing the largest changes on a relative basis. Without the company history comparison, our most followed companies would likely be near the top of the list at all times. A value greater than one indicates a greater than normal number of adds over the last seven days, and a value less than one indicates a less than normal number of adds. If no value is shown, there was not enough activity to generate a value.

Click to close X

We look at the recent net stock shorts (people shorting it in their portfolios minus people covering their short) and compare against the company's previous history to identify those companies that are seeing the largest changes on a relative basis. A value less than -1 (for example -3.6) indicates a greater than normal number of shorts over the last seven days, and a value greater than -1 (for example -0.6) indicates a less than normal number of adds. If no value is shown, there was not enough activity to generate a value.

Click to close X

Thanks for helping us keep tickerspy Indexes accurate!

Let us know which tickers should be added or removed from the Swine Flu and Bird Flu Stocks Index (*RXFLU).

Note: Our tickerspy research team will look at all recommendations but not all of them will be implemented. As a general rule, stocks with a market cap below $50 million will not be included.


Click to close X

Got an idea for an Index we don't have listed? Send it, and our research team will consider it for inclusion.

Note: Our tickerspy research team look at all recommendations but not all of them will be implemented. As a general rule, stocks with a market cap below $50 million will not be included.

Index Name

Tickers(separate with spaces or commas)

Additional comments